AT BEN-GURION UNIVERSITY;B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD.
发明人:
Eli Chaim LEWIS,Yotam LIOR
申请号：
US16499534
公开号：
US20200140524A1
申请日:
2018.04.02
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder.
